The clinical significance of persistently normal ALT in chronic hepatitis B infection.
about
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadKASL clinical practice guidelines: management of chronic hepatitis BAlanine aminotransferase-old biomarker and new concept: a reviewNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentA Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis BCurrent role of transient elastography in the management of chronic hepatitis B patientsFactors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patientsCell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracyChronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infectionA Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelinesEvaluation of the patient with hepatitis BA comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.Natural history of chronic hepatitis B: phases in a complex relationship.Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.Comparison of noninvasive models of fibrosis in chronic hepatitis B.Characteristics of chronic hepatitis B patients who underwent liver biopsies.Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation.Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.AASLD guidelines for treatment of chronic hepatitis B.New approaches in the management of chronic hepatitis B: role of tenofovir.Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALTComparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALTDetermination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese.Antiviral therapies and prospects for a cure of chronic hepatitis B.Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferaseThe role of liver fibrosis assessment in the management of patients with chronic hepatitis B infection: lessons learned from a single centre experienceImmune tolerant hepatitis B: a clinical dilemma.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.DNA-guided hepatitis B treatment, viral load is essential, but not sufficientSerum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.
P2860
Q21144283-87883E2D-2896-4FA8-A987-E9EB7671E78EQ26752475-E69F8098-1BDD-480F-AE28-6DCBA9EC8C7BQ26828819-499D9ECB-87FB-481D-80E7-72B4D911BBDCQ26851211-4E5B1211-A4DD-4E48-971B-4B3A3EA27BF3Q28546931-C7BD6FBA-5197-41DC-9116-AFC3E62FDF29Q30358894-3D880075-8C00-4772-9AF6-3586E631A8BAQ30374334-E0298DA4-B917-4208-9D73-DAA8AAC16F14Q30391932-683F6DA7-D5D1-437C-A90F-9D754EA4C530Q33563893-693CD764-CC9B-4809-8623-ADDB70EFAB33Q33599576-FC7A0D7C-183C-4C4E-9B2A-A9181B992D17Q33714356-02455611-6868-470E-B1CB-67C27020BAFDQ33718958-213B9368-EC27-4E55-A581-720137C467AEQ33808113-66EA339F-78BB-4CC6-9059-67DED809ED72Q33853195-00E9525A-6F89-4F63-B531-E97743477246Q33855708-28CF2D01-C1CA-4F7D-9823-190FB000F988Q33896660-F031BCF8-AAAB-4DED-A5EA-3CD09E412FA4Q33959934-FCD313FD-90C0-4D8E-8BE5-F18A00309E0CQ34036650-0C8C1A88-E075-4382-87B7-890123088567Q34084062-CDBB3B38-29C6-4788-81A0-0CAAE7845CAAQ34137291-1DB09AA2-CED7-4989-85DB-D4CD7D057731Q34184642-B6DB8789-B965-4810-A668-F176CF4806D9Q34199677-B6A50859-41BA-4C83-8060-CCCBC6D31C77Q34414362-C378EECE-F075-4A1A-8208-C70DB4E457A5Q34456589-212CA4D2-E075-4108-8939-A8FBC3213770Q34462246-6C49CC7A-851C-431A-9224-03C6FF94893BQ34501660-D0CE546C-8FB8-416C-830A-C4711D021B29Q35026531-B1538D86-B94D-4ACF-8B13-68DB6C90E22CQ35036631-2C157A51-60AF-4E62-A4A0-48F746417317Q35049139-DEE61028-1707-49E4-A375-40CC43889B0EQ35128204-C80FF5E8-B48B-44AE-A4FB-B8B9CE6F1888Q35245231-A3C97687-1355-4F53-8F2C-C80D36B8775AQ35464781-2B5F267A-A70E-4B13-B9C3-00B4FF00D008Q35495205-734BDD8F-D6C9-4629-B98D-B0D9E264B613Q35691243-893D9F4E-D2A9-4DD8-BA69-C66F90DDD0FEQ36153966-BA7D3B73-02B8-4AFF-8F6A-632CCEFB113FQ36217581-59ACE61F-E9CF-482E-842F-F68E464F0617Q36241726-62805D6D-CAFE-4E3B-AF41-E308529F1339Q36653514-D5DE634B-3237-415F-8FED-2D808F0C6DC4Q37122325-ACD32A30-C465-4A77-A583-95FE467F7853Q37157397-66D55810-3124-43A8-AE80-EB42F2234BEA
P2860
The clinical significance of persistently normal ALT in chronic hepatitis B infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The clinical significance of persistently normal ALT in chronic hepatitis B infection.
@en
type
label
The clinical significance of persistently normal ALT in chronic hepatitis B infection.
@en
prefLabel
The clinical significance of persistently normal ALT in chronic hepatitis B infection.
@en
P2093
P1476
The clinical significance of persistently normal ALT in chronic hepatitis B infection.
@en
P2093
Benjamin J Hyatt
Imad Nasser
Michael Curry
Michelle Lai
P304
P356
10.1016/J.JHEP.2007.07.022
P50
P577
2007-09-24T00:00:00Z